 |
|
CancerSmart Web Cast May 3, 2007 -- Drs. Carol Brown, Nadeem Abu-Rustum, and Paul Sabbatini present, "What You Should Know About the Screening and Treatment of Gynecologic Cancers."
Run time: 71 minutes. |
|
Great progress is being made in the treatment of gynecologic cancers, and Memorial Sloan-Kettering has been an integral part of that advancement.
We believe our most significant impact occurs when we can apply our resources early in the cancer treatment program. Women who choose to have surgery at Memorial Sloan-Kettering benefit from the excellence and experience of our surgical staff. For patients who are just beginning treatment, our medical oncologists are investigating chemotherapy regimens that include novel drugs and drug combinations. We have vast clinical experience in combination chemotherapy and radiation therapy (called combined modality therapy), including high-dose brachytherapy -- a type of internal radiation in which radioactive material is placed directly into or near a tumor.
For women showing the first signs of recurrent uterine cancer, our researchers are working to develop better chemotherapy agents, including novel investigational drugs available only through clinical trials at Memorial Sloan-Kettering. We also have experts devoted to the detection and management of rarer uterine cancers, such as uterine sarcomas.
In addition, we are committed to clinical research that will improve both survival and quality of life for women with endometrial and other uterine cancers.
